PlayReadVIP for Family Child Care
Official title: Adaptation of the PlayReadVIP Intervention to the Family Child Care (FCC) Environment
Run by NYU Langone Health · NCT07489079 · Data updated 2026-11-12
This project tests whether the adapted PlayReadVIP intervention in family childcare settings is doable and may be linked to small improvements in how caregivers interact with children and how kids learn.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | May 27, 2026 |
| Main results expected | April 2027 |
| Study ends | April 2027 |
| Registry record updated | June 1, 2026 |
| Trial ID | NCT07489079 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Family childcare providers or assistants caring for 0–5-year-olds who speak English or Spanish and are 18 years or older.
✕Probably not a fit
Providers who do not adopt the program with fidelity or whose settings are not conducive to the intervention may see no measurable benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-arm study using pre- and post-intervention measurements to see if the adapted PlayReadVIP program can be implemented in Family Care Centers and whether it relates to changes in caregiver practices and child learning outcomes. Researchers will look at how acceptable the program is, how well it is adopted, and whether caregivers deliver it with fidelity. The study will collect both qualitative and quantitative data to describe implementation and any early signals of impact. Participants are adult family childcare providers or assistants who work with children aged 0–5 and speak English or Spanish, in NYU Langone Health settings. Results will inform feasibility and guide future, more rigorous testing if promising.
Why it matters
Potential benefit: If successful, caregivers may be able to implement PlayReadVIP more effectively, potentially supporting better caregiver-child interactions and early learning.
How similar studies have gone: Previous work with PlayReadVIP and similar early-childhood interventions has shown feasibility in community settings, though results vary by context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age or older * Family childcare provider or assistant in MARC Network who cares for children who are 0-5 years of age * English or Spanish-speaking Exclusion Criteria: * Less than 18 years old * Does not speak English or Spanish
Where it's running
-
NYU Langone Health
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Alan Mendelsohn, MD — NYU Langone Health
- Study coordinator: Denise Mazzuchelli
- Email: Denise.Mazzuchelli@nyulangone.org
- Phone: 917-890-1073
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Medial unloader brace after root repair
This study tests whether using a medial unloader brace after arthroscopic medial meniscus posterior root repair helps healing and improves knee outcomes.
-
MAC-STILA: a feasibility test for hip fracture surgery anesthesia
This trial tests whether combining monitored anesthesia care with soft tissue infiltration using local anesthesia can reduce post-operative delirium in adults 65 and older undergoing hip fracture repair.
-
Osimertinib with Cyclosporine A for EGFR-mutant NSCLC
This phase II study tests whether adding cyclosporine A to osimertinib helps people with EGFR-mutant metastatic NSCLC who still have detectable tumor DNA in blood.
-
Histotripsy with chemotherapy and immunotherapy for biliary tract cancer
This pilot test will see if adding histotripsy to chemoimmunotherapy is safe and feasible for adults with biliary tract cancer.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
Virtual Reality Vision Testing for Metamorphopsia and Aniseikonia
A portable virtual reality headset is tested to see if it can more reliably and conveniently measure visual distortions in people with metamorphopsia or aniseikonia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.